Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Brain Neoplasms × Salvage Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Prostatic Neoplasms 2 Recurrence 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Erythroblastic, Acute 1 Hodgkin Disease 1 Brain Neoplasms 1

Interventions

Temozolomide 141 Radiosurgery 103 Radiotherapy 89 Bevacizumab 86 Magnetic Resonance Spectroscopy 59 Carboplatin 46 Etoposide 32 pembrolizumab 30 Irinotecan 30 Cyclophosphamide 30 Surgical Procedures, Operative 28 Nivolumab 28 Erlotinib Hydrochloride 28 Radiation 25 Carmustine 25 Lomustine 23 Filgrastim 21 Cisplatin 21 Trastuzumab 20 Ipilimumab 20 Aminolevulinic Acid 19 Vincristine 18 Mental Status and Dementia Tests 18 Capecitabine 17 Topotecan 16 Specimen Handling 16 Pemetrexed 16 Imatinib Mesylate 14 Gefitinib 14 Thiotepa 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03340129 2026-02-02

ABC-X

Melanoma Institute Australia

Phase 2 Recruiting

CNSDermatologic

Brain Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡